Methods of administering elagolix | Patent Number 10682351

US 10682351 B2
Application Number16722741
Publication NumberUS 20200121680 A1
Pendency5 months, 29 days
Filled DateDec 20, 2019
Priority DateSep 1, 2015
Publication DateApr 23, 2020
Expiration DateAug 31, 2035
Inventor/ApplicantsCheri E. Klein
Sandra L. Goss
Juki Wing-Keung Ng
Ahmed Salem
ExaminesREESE, HEIDI L
Art Unit1657
Technology Center1600
Assignments
Abbvie Inc.
Current
Abbvie Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.